LAV Star
Investment Details
Investor Type
Private Equity
Asset Class Focus
Private Equity
Stage Focus
Early Stage, Mid Stage
Geographical Focus
United States, China
Industries Focus
- Healthcare Services
- Medical Devices
- Diagnostics
- Biopharmaceuticals
Investor Details Founded: 2008
LAV Star is a biomedical venture capital firm with offices in Hong Kong, Shanghai, and Palo Alto. Founded in 2008, the firm focuses on investments in biopharmaceuticals, human therapeutics, medical devices, and diagnostics. Their vision is to become the trusted partner for exceptional entrepreneurs seeking smart capital to develop breakthrough products that treat diseases and improve human health.
The firm manages committed capital of over USD2.33 billion and has invested in over 80 portfolio companies worldwide. LAV Star is managed by a team of professionals with substantial biomedical domain expertise and extensive investing experience in China. Their investment strategy emphasizes long-term thinking, betting on people, products, and quality science.
LAV Star's portfolio includes notable companies such as CanSino Biologics Inc., Jacobio Pharmaceuticals Group Co., Ltd., RemeGen Co., Ltd., and New Horizon Health Limited. The firm has a strong track record in supporting innovative companies that develop products to address unmet medical needs and improve patient outcomes.
Requirements
- Focus on biopharmaceuticals, human therapeutics, medical devices, and diagnostics
- Target companies in China and the United States
- Preference for early to mid-stage investments with strong scientific foundations
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- CanSino Biologics Inc.
- Jacobio Pharmaceuticals Group Co., Ltd.
- RemeGen Co., Ltd.
- New Horizon Health Limited
Claim this Investor
Are you an official representative of LAV Star?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim